Evolus, Inc. (EOLS)
$7.73-0.90%Close
SELLBEAR · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $509M
- Beta
- 1.34
- P/E (TTM)
- -14.25
- Short % float
- 11.25%
- Days to cover
- 9.3
- SI change
- +1.8%
- 1W
- +8.26%
- 1M
- -2.28%
- vs SPY 1W
- +7.10%
- vs SPY 1M
- -5.27%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on EOLS?
- LOPJLB’s latest quantitative signal on Evolus, Inc. (EOLS) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is EOLS in?
- Evolus, Inc. (EOLS) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Evolus, Inc. (EOLS) do?
- Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabell…